The company's principal activity is to design, manufacture, market and service advanced medical imaging devices using positron emission tomography technology. The company markets its product under the trademark posicam (TM) . Posicam(tm) systems incorporate patented and proprietary technology and enable physicians to diagnose and treat patients in the areas of cardiology, neurology and oncology. The products of the company are sold to medical institutions. Company operates solely operates in the United States.
